Sign in

CIK 0001857044 · Non-accelerated filer<br>Smaller reporting company

Indaptus Therapeutics, Inc.

Sign in to watch
Ticker
INDP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
863158720
Phone
(646) 427-2727
Business address
3 COLUMBUS CIRCLE, 15TH FLOOR, NEW YORK, NY, 10019
Former names
Intec Parent Inc.
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Open-market buy Chief Medical Officer bought 1,150 shares at an average $2.19 ($2,520)
  6. 4 Open-market buy CEO and Director bought 10,000 shares at an average $1.89 ($18,945)
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Open-market buy CEO and Director bought 10,308 shares at $2.80 ($28,862)
  14. 4 Open-market buy Chief Business Officer bought 150 shares at $2.62 ($393)
  15. 4 Open-market buy CEO and Director bought 9,692 shares at an average $2.56 ($24,771)
  16. 3 Insider Initial Statement of Ownership
  17. 4 Open-market buy CEO and Director bought 19,727 shares at $2.63 ($51,882)
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 3 Insider Initial Statement of Ownership

Page 4 of 6 · 108 filings